What are you looking for? Search Common searches: Departments, Hospitalisation, Professionals, Outpatient clinics, Health advice, Accreditations, Diseases, Diagnostic tests, Treatments, The birth of a child, Emergency, Visiting patients, Fulltext search Tipus de contingut Services and units Professionals Pathologies Health advices Health and wellness Diagnostic tests Treatments News Activities Centers - Any - Search News A pioneering study by Vall d'Hebron demonstrates the efficacy of a new recovery protocol for patients with advanced ovarian cancer The Enhanced Recovery After Surgery (ERAS) protocol allows patients undergoing surgery for advanced ovarian cancer to be discharged from hospital up to 2 days earlier and decrease their readmission rate. News Vall d'Hebron participates in the CombivacS clinical trial that will evaluate a second dose of the Pfizer vaccine to people already vaccinated with a dose of AstraZeneca The trial aims to provide scientific evidence to support decision-making regarding a possible alternative to complete immunization in people under 60 vaccinated with a dose of AstraZeneca. News An international study involving Vall d’Hebron shows that COVID-19 increases the risk of complications during pregnancy The INTERCOVID project finds that infected women are 50% more likely to have complications during pregnancy. News Vall d'Hebron begins two clinical trials to test a new system to filter blood and improve the evolution of COVID-19 and sepsis Seraph 100 consists of a filter capable of binding and eliminating microorganisms in the blood of patients who have an infection. The clinical trials that are now underway will study whether this system can reduce the severity of critical patients with COVID-19 and sepsis. News Dr. Joan Comella is appointed treasurer of ICORD and Dr. Mireia del Toro joins the board International Conference of Rare Diseases and Orphan Drugs (ICORD) is a world reference organization in rare diseases. News Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder These findings open the way for research into new therapeutic targets, as well as for the study of the possibility of reusing drugs that are already used in other illnesses for the treatment of bipolar disorder. News Vall d’Hebron identifies memory immune cells in blood and lungs essential for the control of SARS-CoV-2 Researchers have found lung-resident memory T lymphocytes months after SARS-CoV-2 infection, which would rapidly activate in the event of possible reinfection. News Vall d’Hebron has reached a record number of clinical trials despite the pandemic 2020 ended with the highest number of clinical trials recorded at the Vall d’Hebron Campus, which includes the Vall d'Hebron Research Institute (VHIR) and the Vall d'Hebron Institute of Oncology (VHIO): 1,365 active and 319 new. News Vall d’Hebron begins the clinical trial in pregnant women of the Pfizer and BioNTech vaccine against COVID-19 The study will evaluate the safety, immunogenicity and efficacy of the vaccine in pregnant women, the passive transfer of antibodies to the fetus and the protection conferred during lactation. News A work led by Vall d'Hebron demonstrates the relationship between immune-mediated inflammatory diseases and changes in diet The study, carried out with more than 11,000 patients, aims to understand the effect of food on these diseases to give recommendations based on evidence. Pagination Previous page ‹‹ Page 120 Next page ››